Bookmark Add to Calendar

510 (k) and PMA Refuse to Accept Policy

4608
Duration : 60 Minutes

Charles H. Paul,

Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm. Charles is a management consultant, instructional designer and regulatory consultant and has led C. H. Paul Consulting, Inc. since its inception over 25 years ago. He regularly consults Read more


This webinar will overview the important critical content of these two revised documents to include the most important checklists that are contained in the Refuse to Accept Policy guidance that provides acceptability criteria for each 510(k) – Traditional, Abbreviated, and Special.

The checklists clarify the content needed in traditional, special, and abbreviated 510(k) submissions to allow FDA to conduct a substantive review, thereby enhancing the quality of received 510(k) submissions and improving overall review time.

The Acceptance and Filing Reviews for Premarket Approval Applications (PMAs) contains other critically important checklists that cover the acceptance review criteria for PMAs.

This document also addresses medical device products which include drug components.  The guidance outlines new requirements direct registrants to include drug patent information as well as any exclusive marketing rights that may cover a combination product’s drug component. The FDA requires this information as a factor in determining whether applications are complete and can proceed to more in-depth reviews.

Course Objectives:

The key learning objectives addressed by this webinar include:

• List and describe the contents of the Refuse to accept 510 (k) and Acceptance and Filing Reviews for Premarket Approval Applications Guidance Documents
• Identify the critical components of each Guidance Document
• List and describe the five preliminary questions that are identified in the Refuse to Accept for 510 (k) document
• List and describe the contents application of the checklists contained in each guidance document

Why Should You Attend:

The key takeaways or learnings from this Webinar include that:

In early 2018, the US FDA updated its Premarket Approval (PMA) acceptance process and Refuse to Accept policy for initial reviews of 510(k) submissions.

The primary issues that these documents seek to rectify is the number of incomplete and/or inadequate PMAs that are submitted each year and it is the intent of the FDA going forward that they will no longer accept submissions that do not meet their standard of acceptability.

Course Outline:

The specific content to be covered in this webinar includes the following:

• Refuse to Accept for 510 (k)

o Guidance overview
o Acceptance review timing
o Five preliminary questions
o Checklist review

• Acceptance and Filing Reviews for Premarket Approval Applications (PMA)s

o Guidance overview
o Grounds for refusing to accept an application
o Combination product administrative items
o Checklist

What You Get:

•  Training Materials
•  Live Q&A Session with our Expert
•  Participation Certificate
•  Access to Signup Community (Optional)
•  Reward Points

Who Will Benefit:

This webinar will provide valuable assistance to medical device companies in managing their Design History Files. The employees who will benefit include:

• Quality System auditors
• Engineering managers and personnel
• Regulatory Affairs
• Product development engineers

Please reach us at 1-888-844-8963 for any further assistance or if you wish to register

100% MONEY BACK GUARANTEED

Refund / Cancellation policy

Get In Touch

Subject : 510 (k) and PMA Refuse to Accept Policy


Similar Trainings

Understanding Combination Products: Navigating the Rules and Regulations
LIVE : Scheduled on 30-April-2024 :01:00 PM EDT
European Union Device Regulation (EU MDR)
LIVE : Scheduled on 01-May-2024 :01:00 PM EDT
Risk Based Design Control
LIVE : Scheduled on 15-May-2024 :01:00 PM EDT
paypal payment Comodo

Copyright ©2024 Signup Training. All rights reserved.